Lipid microspheres as novel drug carriers
Mizushima, Y.
Drugs under Experimental and Clinical Research 11(9): 595-600
1985
ISSN/ISBN: 0378-6501 PMID: 3880046 Document Number: 251295
Lipid microsphere preparations of corticosteroid, non-steroid anti-inflammatory drugs and prostaglandin E1 (PGE1) all showed more potent activity than the free drugs. Lipo-PGE1 in particular was significantly more active than free PGE1 at about one-tenth the dose of free PGE1. A large mass of data obtained in studies of liposomes suggest many applications for the lipid microsphere, which is considered to be a very promising carrier in drug delivery systems.
Document emailed within 1 workday
Related Documents
Mizushima, Y.; Shoji, Y.; Kato, T.; Fukushima, M.; Kurozumi, S. 1986: Use of lipid microspheres as a drug carrier for antitumour drugs Journal of Pharmacy and Pharmacology 38(2): 132-134Hoshi, K.; Mizushima, Y.; Kiyokawa, S.; Yanagawa, A. 1986: Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy Drugs under Experimental and Clinical Research 12(8): 681-685
Honda, A.; Mori, Y.; Yamada, Y.; Nakaike, S.; Hayashi, H.; Otomo, S. 1988: Prolonged survival time of sarcoma 180-bearing mice treated with lipid microspheres-entrapped antitumor marine coral prostanoids Research Communications in Chemical Pathology and Pharmacology 61(3): 413-416
Suhaida, M.G.; Yahya, I.B.; Darmawati, M.Y. 2004: Preparation of naltrexone hydrochloride loaded poly (DL-lactide-co-glycolide) microspheres and the effect of polyvinyl alcohol (PVA) as surfactant on the characteristics of the microspheres Medical Journal of Malaysia 59 Suppl B: 63-64
Skupchenko, A.V.; Lysenko, A.V.; Korolev, D.G.; Skobel'tsov, D.A.; Rassudishkin, A.S. 2014: Chemoembolization for unresectable colorectal liver metastases with drug-eluting microspheres Vestnik Rentgenologii i Radiologii 6: 33-38
Makarov, V.K. 2003: The effect of alcohol on serum lipid composition in hepatitis B virus carriers Gigiena i Sanitariia 1: 38-40
Riangjanapatee, P.; Müller, R.H.; Keck, C.M.; Okonogi, S. 2013: Development of lycopene-loaded nanostructured lipid carriers: effect of rice oil and cholesterol Die Pharmazie 68(9): 723-731
Pardeike, J.; Schmidt, C.; Volz, I.; Müller, R.H. 2011: Nanostructured lipid carriers as delivery system for the phopholipase A2 inhibitors PX-18 and PX-13 for dermal application Die Pharmazie 66(5): 357-361
Gao, Q.-h.; Zheng, G.-j.; Wang, C.-g.; Zhou, L.; Wen, Y.-m.; Wang, C.-m.; Hou, S.-x. 2005: An experirmental study on the preparation and drug sustained release characteristics of Pingyangmycin Albumin Microspheres Hua Xi Kou Qiang Yi Xue Za Zhi 23(1): 69-71
Altomonte, L.; Mingrone, G.; Ghirlanda, G.; Manna, R.; Rebuzzi, A.; Pala, M.A.; Greco, A.V. 1980: Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate) Minerva Medica 71(4): 273-278
Li, H.; Wen, Y.; Wang, C. 2003: Study on drug release after arterial embolism with cisplain-loaded albumin microspheres in treating carcinoma of tongue Hua Xi Kou Qiang Yi Xue Za Zhi 21(2): 112-113; 139
Gorbach, V.I.; Luk'ianov, P.A.; Solov'eva, T.F.; Ovodov, I.S. 1985: Synthesis of lipid a analogs. Obtaining conjugates of 6-phosphate 2-desoxy-2-(3-hydroxymyristoyl)amino-D-glucose with polymer carriers and their immunological properties Bioorganicheskaia Khimiia 11(5): 677-682
Flury, F.; Modde, H. 1971: Drug containers as possible carriers of infection in hospital Pharmaceutica Acta Helvetiae 46(6): 361-376
Tang, H.-x.; Zhang, Z.-h.; Zhao, Z.-y.; Lü, H.-x. 2015: Research progress of lactoferrin as drug carriers Yao Xue Xue Bao 50(6): 675-681
Tamilvanan, S.; Venkatesh Babu, R.; Kannan, K.; Basu, S.K.; Sa, B. 2008: Manufacturing techniques and excipients used during the design of biodegradable polymer-based microspheres containing therapeutic peptide/protein for parenteral controlled drug delivery PDA Journal of Pharmaceutical Science and Technology 62(2): 125-154
Fusai, T.; Durand, R.; Boulard, Y.; Paul, M.; Bories, C.; Rivollet, D.; Houin, R.; Deniau, M. 1995: Importance of drug carriers in the treatment of visceral leishmaniasis Medecine Tropicale: Revue du Corps de Sante Colonial 55(1): 73-78
Fang, J.-Y. 2006: Nano- or submicron-sized liposomes as carriers for drug delivery Chang Gung Medical Journal 29(4): 358-362
Torkhovskaia, T.I.; Ipatova, O.M.; Medvedeva, N.V.; Ivanov, V.S.; Ivanova, L.I. 2010: Plasma lipoproteins as drug carriers. Effect of phospholipid formulations Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 5: 42-50
Yi, C.-x.; Yu, J.-n.; Xu, X.-m. 2008: Nanoscale drug carriers for traditional Chinese medicine research and development Zhongguo Zhong Yao Za Zhi 33(16): 1936-1940
Midro, A.T.; Wiśniewski, L.; Krajewska-Walasek, M.; Szymańska, J. 1989: Risk of reproduction disorders in carriers of mutual chromosomal translocations, and methods for detection of translocation carriers Ginekologia Polska 60(7-9): 380-386